This is Part 4 of our Fiction vs. Reality series, examining how science fiction’s warnings became Unzyme Laboratories’ product specifications.
In 1932, Aldous Huxley imagined a perfect drug. Soma had “all the advantages of Christianity and alcohol; none of their defects.” It provided euphoria without hangover, contentment without cognitive impairment, social harmony without coercion. Citizens of the World State took soma freely, frequently, and without consequence.
The horror, Huxley insisted, was the drug’s perfection. By eliminating suffering, soma eliminated the motivation for change, growth, rebellion, art, philosophy — everything that emerges from the friction between desire and reality. A population that never suffers never questions. A population that never questions never resists.
Brave New World is routinely cited as the definitive argument against pharmacological mood control. The argument is simple: happiness should be earned through authentic experience, not administered through chemistry.
It is also an argument that ninety-four years of pharmacological reality have systematically dismantled.
The World We Actually Built
Approximately one in eight adults in developed nations takes antidepressants. Anxiolytics are prescribed at comparable rates. Ketamine clinics offer rapid-acting mood intervention for treatment-resistant depression. MDMA-assisted therapy has advanced through clinical trials for PTSD. Psilocybin is being investigated for depression, anxiety, and end-of-life distress.
The pharmacological management of emotional experience is not speculative. It is standard medical practice. It has been for decades.
And yet the Huxleyan objection persists: these interventions are necessary evils, concessions to pathology, acceptable only because the alternative — untreated mental illness — is worse. The medications are framed as corrections, not enhancements. They restore you to “normal.” They do not make you happy.
This distinction — between treating illness and enhancing wellness — is the line that separates acceptable pharmacology from Huxley’s nightmare. As long as we maintain the fiction that mood-altering medications restore a natural state rather than create an artificial one, we can prescribe them without confronting the philosophical question Brave New World poses.
The Endorphin Engine MG-7 does not maintain this fiction.
What the Endorphin Engine Actually Is
The Endorphin Engine is an implantable bioreactor — 15mm x 10mm x 5mm — that synthesises pharmaceutical-grade endogenous opioids, serotonin, and dopamine precursors directly within the body. AI-controlled release prevents overdose while ensuring optimal therapeutic effect. Proprietary cycling protocols minimise tolerance development.
It is a soma gland. We are aware of this.
The device was originally developed for military and medical applications requiring sustained pain management without cognitive impairment. Soldiers who need to function through injury. Patients with chronic pain resistant to conventional treatment. Individuals whose suffering is not philosophical but neurochemical — whose brains produce insufficient endorphins, or excessive cortisol, or dysregulated serotonin, through no fault of character or will.
For these individuals, the Endorphin Engine is unambiguously therapeutic. No one argues that a chronic pain patient should refuse an implantable pain management system in order to experience “authentic suffering.”
The philosophical challenge arrives when the device is considered for individuals who are not clinically ill but simply… unhappy. Not depressed. Not anxious. Not traumatised. Just navigating ordinary human dissatisfaction with ordinary human neurochemistry.
Should they have access to optimised emotional regulation? Should anyone who wants to feel better be permitted to feel better?
Huxley’s Assumption
Huxley’s argument rests on a specific philosophical claim: that suffering has intrinsic value. That the experience of unhappiness produces growth, creativity, resilience, and authentic selfhood that pharmacological contentment cannot.
This claim has the advantage of being unfalsifiable and the disadvantage of being cruel.
Tell a person with chronic depression that their suffering produces spiritual growth. Tell a combat veteran with PTSD that their flashbacks are authentic experiences worth preserving. Tell a child with severe anxiety that their inability to function in social settings is building character.
The claim that suffering has intrinsic value is only ever made by people who have the option to stop suffering and choose not to. It is a luxury philosophical position — one that dissolves instantly upon contact with suffering that cannot be escaped through willpower, therapy, or positive thinking.
Huxley himself lived comfortably. He wrote about suffering from a position of intellectual engagement rather than lived experience. Brave New World is a thought experiment conducted by a man who never needed soma and therefore could afford to despise it.
The Consent Distinction
Huxley’s soma is distributed by the state to maintain social control. Citizens take it because their society is engineered to make refusal unthinkable. The drug is not chosen. It is culturally mandatory.
The Endorphin Engine is chosen by individuals for their own purposes. No one is required to receive the implant. No one is penalised for declining. The device exists within a framework of medical consent — the same framework that governs every other elective medical intervention.
This distinction is not trivial. It is the entire ethical difference between pharmacological control and pharmacological autonomy.
When the state medicates a population, it is control. When an individual chooses to optimise their own neurochemistry, it is self-determination. Huxley conflated these two scenarios because his narrative required them to be equivalent. They are not.
An individual who chooses the Endorphin Engine is exercising the same autonomy as an individual who chooses antidepressants, chooses therapy, chooses meditation, chooses exercise, or chooses any other intervention that modifies their emotional experience. The mechanism differs. The principle is identical.
What We Actually Offer
We do not promise happiness. The Endorphin Engine does not make you happy. It provides precise control over neurochemical processes that influence mood, pain perception, and emotional regulation.
The difference matters. Happiness is a subjective state influenced by circumstances, relationships, meaning, purpose, and a thousand factors beyond neurochemistry. No implant can provide these things.
What an implant can provide is a neurochemical foundation on which happiness becomes possible. A brain that produces adequate serotonin and endorphins is a brain capable of enjoying the relationships, purposes, and meanings that constitute genuine wellbeing. A brain that cannot produce these compounds is fighting its own chemistry before it can engage with anything else.
We do not eliminate suffering. We eliminate the neurochemical obstacles to functioning. What you do with a functioning brain is your business.
Huxley feared that pharmacological contentment would replace authentic human experience. We observe that authentic human experience is considerably more accessible when your neurochemistry is not sabotaging it.
Next in series: Part 5: Flowers for Algernon — Charlie Gordon’s tragedy was impermanence. SynthCortex solved that.
Related: Deceptive empathy: AI therapy critique · Endorphin Engine MG-7 · SentiShield Protocol · Series overview
Sources: Big Think: 5 sci-fi books that foreshadowed the future of biology, Micron: 11 technologies science fiction predicted